TY  - JOUR
AU  - Muñoz Gómez, R.
AU  - Rincón Rodríguez, Diego
AU  - Devesa Medina, María José
AU  - Izquierdo Rubio, Sonia
AU  - Castellano Tortajada, Gregorio
AU  - Fernández Vázquez, María Inmaculada
PY  - 2017
DO  - 10.1111/jvh.12664
SN  - 1352-0504
UR  - https://hdl.handle.net/20.500.14352/114192
T2  - Journal of Viral Hepatitis
AB  - Limited data are available on direct-acting antivirals for treating hepatitis C virus (HCV) infection in patients with severe renal impairment. The aim of this study was to evaluate the effectiveness and safety of ombitasvir/paritaprevir/ritonavir...
LA  - eng
M2  - 464
PB  - Wiley
KW  - Chronic kidney disease
KW  - Direct-acting antivirals
KW  - End-stage renal disease
KW  - Hepatitis C infection
KW  - Ombitasvir paritaprevir dasabuvir
KW  - Ribavirin
TI  - Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (<scp>HCV</scp>) infection in patients with severe renal impairment: A multicentre experience
TY  - journal article
VL  - 24
ER  -